Damora Therapeutics, Inc. (DMRA) — Defensive Interval Ratio
Damora Therapeutics, Inc. (DMRA) has a Defensive Interval Ratio of 16 days as of December 2025. Defensive assets of $899.00K (cash $-, short-term investments $-, receivables $899.00K) cover 16 days of daily cash needs of $54.98K/day. For the complete balance sheet picture, see DMRA total asset value.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Damora Therapeutics, Inc. Defensive Interval Ratio (2018–2025)
This chart shows how Damora Therapeutics, Inc.'s Defensive Interval Ratio has evolved across 8 annual periods from 2018 to 2025. As of December 2025, the ratio stands at 16 days, meaning defensive assets of $899.00K can fund 16 days of operations without new revenue. Check asset resilience ratio of Damora Therapeutics, Inc. to evaluate the company's liquid asset resilience ratio.
Annual Defensive Interval Ratio for Damora Therapeutics, Inc. (2018–2025)
The table below presents the year-by-year Defensive Interval Ratio for Damora Therapeutics, Inc. from 2018 to 2025, covering 8 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 16 days | $899.00K | $54.98K/day | $- | $- | ▼ -252 days |
| 2024 | 269 days | $881.00K | $3.28K/day | $- | $0.00 | ▼ -571 days |
| 2023 | 839 days | $13.40 Million | $15.97K/day | $- | $11.69 Million | ▼ -108 days |
| 2022 | 947 days | $28.82 Million | $30.43K/day | $- | $27.44 Million | ▼ -2259 days |
| 2021 | 3206 days | $39.91 Million | $12.45K/day | $- | $37.63 Million | ▲ +3061 days |
| 2020 | 145 days | $2.21 Million | $15.25K/day | $- | $- | ▼ -1749 days |
| 2019 | 1894 days | $41.13 Million | $21.72K/day | $- | $- | ▲ +1813 days |
| 2018 | 81 days | $989.00K | $12.18K/day | $- | $- | — |